IC14 for Rapidly Progressive Amyotrophic Lateral Sclerosis (ALS)

Summary

Patients with rapidly progressive ALS will be assigned to IC14 intravenously on Day 1-4. This 4-day course will be repeated on Days 8-11. Patients will all undergo MR-PET scans at two time points: before treatment onset and after the last treatment cycle. This scan will measure areas of ALS disease activity and assess response to IC14 treatment. MR-PET scans will be compared to historical controls.

Timeline

Start

2019-09-01

Primary completion

2021-04-12

Completion

2021-07-12

Drugs

Indications